The Hematologist: Recent Episodes
The Hematologist
The Hematologist is the member newsletter of American Society of Hematology (ASH). It is designed for the broad constituency of ASH, all working toward the ultimate goal of conquering blood diseases. The Hematologist updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
In this episode, Contributing Editor Dr. Robert Hasserjian has a conversation with Dr. Siddhartha Jaiswal about a recent paper Dr. Jaiswal co-authored: “Aberrant activation of TCL1A promotes stem cell expansion in clonal haematopoiesis.”
Dr. Hasserjian is a professor of pathology at Harvard Medical School. He is also the director of the Hematopathology Fellowship Program at Massachusetts General Hospital. Dr. Jaiswal is an assistant professor of pathology at Stanford University School of Medicine.
Dr. Hasserjian wrote about Dr. Jaiswal’s paper in his recent Diffusion article in The Hematologist. You can access his Diffusion article online at: https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V20.4.202344/496652/Genetic-Background-Influences-the-Growth-of-CHIP
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this episode, Drs. Robert Stern and Ronak Mistry talk about their own professional journeys as hematologists, why they love what they do, the medical education for hematologists, and recruitment efforts to bring more students into the field.
Dr. Stern is the associate program director with the Dana-Farber Massachusetts General Brigham Fellowship in Hematology and Oncology in Boston.
Dr. Mistry is a clinical fellow in the division of hematology and oncology at Vanderbilt University Medical Center in Nashville.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
En este episodio, el Dr. Rubén Mesa entrevista al Dr. Diego Adrianzen-Herrera y la Dra. Joanna Robles en honor del Mes de la Herencia Hispana sobre sus experiencias como hematólogos de ascendencia hispana/latina, la importancia de ASH y un buen mentor en sus carreras, lo que los llevó a estudiar medicina, y la forma de garantizar que la comunidad hispana tenga una voz en el sector de la hematología. Para obtener información adicional, visite www.hematology.org/DEI.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment, Dr. Ruben Mesa leads a conversation in honor of Hispanic Heritage Month, in an interview with Dr. Diego Adrianzen-Herrera and Dr. Joanna Robles. They share their experiences as hematologists of Hispanic/LatinX heritage and discuss the role of mentorship and ASH in their work, what led them to their careers in medicine, and what they as individuals can do to ensure the Hispanic/LatinX community has a voice in the field. Contributing a special introduction to the conversation is Dr. Belinda Avalos, an outspoken leader in diversity, equity, and inclusion in hematology. For more information on the Society's diversity, equity, and inclusion efforts, please visit www.hematology.org/DEI.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment, Contributing Editor Dr. David Rees has a conversation with Drs. Naja Nyffenegger and Vania Manolova. They discuss the Blood article covered by Dr. Rees in his most recent Diffusion article titled, “Iron-restricted Erythropoiesis in Sickle Cell Disease.” In the article, Dr. Rees explored the study by Dr. Nyffenegger and colleagues, which hypothesized that iron restriction via blocking ferroportin might reduce sickle hemoglobin concentration in red blood cells, thereby decreasing hemolysis, improving blood flow, and preventing vaso-occlusive events. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.5.202256/486443/Iron-restricted-Erythropoiesis-in-Sickle-Cell.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this episode, Dr. Jennifer Holter-Chakrabarty, chair of the ASH Committee on Government Affairs, and Dr. Sarah O’Brien, chair of the ASH Working Group on Maternal Health in Hematology have a conversation about recent issues facing maternal health care, and what the Society and its membership is doing to confront these challenges, through advocacy and education.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment, Contributing Editor Dr. Loretta Nastoupil has a conversation with Dr. Melody Smith. They discuss a Nature Medicine article covered by Dr. Nastoupil in her most recent Diffusion article titled, “Trust Your Gut: Changes in Intestinal Microbiome Are Associated With Outcomes Following CAR-T Therapy.” In the article, Dr. Nastoupil discusses a study that explored whether antibiotic exposure or fecal microbiome composition was associated with efficacy and toxicity following anti-CD19 chimeric antigen receptor T-cell therapy in adult patients with B-cell malignancies. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.4.202247/485636/Trust-Your-Gut-Changes-in-Intestinal-Microbiome.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment, ASH Committee on Practice Chair Dr. Chancellor Donald and ASH Committee on Government Affairs Chair Dr. Jennifer Holter Chakrabarty provide an overview of the latest sickle cell disease (SCD) policy updates and highlight ASH's work to date on the Hill, including a recently introduced SCD bill, and work with the U.S. Department of Health and Human Services and other federal partners. Learn more and get involved by visiting www.hematology.org/advocacy.
PLEASE NOTE: During their conversation, Drs. Donald and Holter Chakrabarty discuss the Sickle Cell Disease Comprehensive Care Act (H.R. 6216/S. 3389), bipartisan legislation introduced in December 2021 that seeks to create a demonstration program in up to 10 states to improve access to comprehensive, high-quality, outpatient care for individuals with SCD enrolled in Medicaid. Dr. Holter Chakrabarty mentions a number of specific states that may benefit if the legislation passes Congress and is signed into law. We would like to clarify that none of the states Dr. Holter Chakrabarty mentions are guaranteed participation in the demonstration program. However, under the guidelines set forth in the legislation, priority for participation will be given to states that participate in the Centers for Disease Control and Prevention (CDC) Sickle Cell Data Collection program (which the states mentioned by Dr. Holter Chakrabarty are all participants in), as well as states with a high prevalence of individuals living with SCD.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment, Contributing Editor Dr. Christine McMahon has a conversation with Dr. Ivy Abraham. They discuss a Blood article covered by Dr. McMahon in her most recent Diffusion article titled, “Toward Understanding Disparities in AML Outcomes: The Role of Structural Racism.” In the article, Dr. McMahon discusses an analysis of data showing disparities in acute myeloid leukemia (AML) outcomes among racial and ethnic groups as well as the reason these disparities exist. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.3.202239/484980/Toward-Understanding-Disparities-in-AML-Outcomes.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment, Editor-in-Chief Dr. Laura Michaelis interviews Dr. Shikha Jain. In this interview, Dr. Michaelis and Dr. Jain chat about female physicians' experience in the workforce, women in medicine, and discuss a series of articles and studies on why they are leaving the workforce and how their experiences compare to their male counterparts. Visit the ASH website to learn about the Society's Women in Hematology Working Group's efforts via https://www.hematology.org/diversity-equity-and-inclusion/women-in-hematology-working-group.
About Dr. Jain:
Dr. Jain’s clinical focus is GI oncology with a special interest in neuroendocrine tumors, colorectal cancer, and hepatocellular carcinoma (liver cancer). Her research interests include neuroendocrine tumors, immunotherapy, colorectal and pancreatic cancers, hepatocellular carcinoma advances in cancer therapy, the impact of social media in medicine, health care communication, and health care and gender equity. She works to incorporate patient education and outreach in her patients’ treatment and believes in personalized and individualized care. Dr. Jain founded and is the CEO of the COVID-19 action and advocacy group IMPACT. She founded and co-chaired the inaugural Women in Medicine Symposium at Northwestern Memorial Hospital in Chicago in 2018, which focused on promoting the advancement of women physicians at Northwestern. She is co-founder of the Rush Center for the Advancement of Women in Health Care. Learn more about her accomplishments and work at https://shikhajainmd.com/.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
English Version: In this podcast, 2022 ASH Guidelines for Prevention of Venous Thromboembolism in Latin American panel members Dr. Patricia Casais and Dr. Luis Meillon-Garcia have a conversation about the clinical importance of new Guidelines on Venous Thromboembolism in Latin America in medical and surgical patients and long-distance travelers in Latin America. Learn more by visiting www.hematology.org/vte, and read the full guideline in a Blood Advances publication via https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021006482/484109/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU.
Additional membership and affiliation information for our speakers: Dr. Patricia Casais is a panel member of the ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOMETH, Sociedad Panameña de Hematología, SPH, SVH, 2022 Guidelines for Prevention of VTE in Latin America. Dr. Luis Meillon-Garcia is a member of the academic board of SOMETH (Sociedad Mexicana de Trombosis y Hemostasia).
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this podcast, Contributing Editor Dr. Beth Psaila has a conversation with Dr. Hamza Celik. They discuss a Cancer Discovery article covered by Dr. Psaila in her most recent Diffusion article titled, “Modeling Myelofibrosis in Vivo: Success With NSG-S.” In the article, Dr. Psaila discusses an optimized approach for engrafting myelofibrosis CD34+ stem/progenitor cells from peripheral blood of patients into immunodeficient mice called NSG-S, as a successful model of myelofibrosis in an in vivo setting. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.2.202222/484169/Modelling-Myelofibrosis-in-Vivo-Success-With-NSG-S.
Additional information about Dr. Celik: Dr. Hamza Celik joined Incyte Research Corporation in 2020 as a principal investigator in pre-clinical pharmacology. At the time he contributed to the article referenced in Dr. Psaila’s Diffusion and in this podcast, he was in the process of completing his postdoctoral work in normal and malignant hematopoiesis under the supervision of Dr. Grant Challen at the Washington University of St. Louis.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Spanish Version/Versión en Español: En este pódcast, miembros del Panel LATAM ASH TEV, Dra. Cecilia Colorio y Dra. Cecilia Guillermo, conversan sobre la importancia clínica de las nuevas Guías Para la Prevención del Tromboembolismo Venoso para América Latina, en pacientes quirúrgicos, médicos, y viajeros de larga distancia. Visite www.hematology.org/vte para mٔás información y lea las guías completas en una publicación de Blood Advances: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021006482/484109/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Portuguese Version/Versão em Português: Neste podcast, Doutora Suely Rezende e Doutor Daniel Ribeiro, membros do Painel LATAM ASH TEV, conversam sobre a importância clínica das novas Diretrizes Para a Prevenção do Tromboembolismo Venoso em pacientes cirúrgicos e hospitalizados, e viajantes de longa distância na América Latina. Visite www.hematology.org/vte para mais informações e leia as diretrizes completas na publicação da Blood Advances: https://ashpublications.org/bloodadvances/article/doi/10.1182/bloodadvances.2021006482/484109/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment, Editor-in-Chief Dr. Laura Michaelis interviews Dr. Rayne Rouce. Amazing doctors are leading the way for a future generation of hematologists through their inspiring work and intentional commitment to make a positive change in the medical field. In this interview, Dr. Michaelis and Dr. Rouce chat about Dr. Rouce’s work with children as a pediatric hematologist/oncologist, in the lab, her work with advocacy and promoting diversity in health care, and her passion for music that has led to a rap career inspiring youth.
Dr. Rayne Rouce is an avid volunteer who has dedicated her professional and personal life to enhancing the lives of children with cancer and blood disorders, both within and outside the hospital. She is an avid advocate, working for 15 years with The Periwinkle Foundation’s events and programs for children with cancer and other life-threatening diseases and community engagement STEM initiatives to enhance K-12 exposure to science and medicine. Thanks to her fluency in Spanish, she has been able to not only provide comprehensive care to her patients, but has also volunteered in the past to care for children around Texas and in small villages in Bolivia. She is a member of the ASH Committee on Diversity, Equity, and Inclusion and Committee on Promoting Diversity liaison for the ASH Awards Committee. Dr. Rouce received the ASH-AMFDP Award in 2016, is an inaugural participant of the ASH Ambassador Program, and served as faculty for the 2020 and 2021 ASH Clinical Research Training Institute.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this podcast, Editor-in-Chief Dr. Laura Michaelis has a conversation with Contributing Editor Dr. Kristen O'Dwyer. They discuss Dr. O'Dwyer's pick for the best of 2021 on achieving a second remission in patients with acute lymphoblastic leukemia (ALL). You can access her Year's Best article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V19.1.2022110/483386/From-Myth-to-Reality-Achieving-a-Second-Remission.
Additional disclaimer: Dr. Kristen O'Dwyer contributed to/was an author on the ZUMA-3 trial.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment of our 2021 ASH Annual Meeting Podcast series, Contributing Editor Dr. Brad Kahl has a conversation with Contributing Editor Dr. Frederick Locke about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract presents an analysis of the ZUMA-7 trial of axicabtagene ciloleucel versus standard-of-care therapy in patients with relapsed/refractory large B-cell lymphoma.
For coverage of the plenary scientific session, including this abstract and many other sessions, check www.ashpublications.org/ashnewsdaily throughout the meeting.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment of our 2021 ASH Annual Meeting Podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with ASH Secretary Dr. Cindy Dunbar about the COVID-19–related content that will be presented at the 2021 ASH Annual Meeting.
For coverage of abstracts, sessions, and other events, check www.ashpublications.org/ashnewsdaily throughout the meeting. Visit www.hematology.org/covid-19 for a list of related sessions at this year's meeting.
While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment of our 2021 ASH Annual Meeting Podcast series, Editor-in-Chief Dr. Laura Michaelis has a conversation with Dr. Guy Young about his work on one of the plenary abstracts that will be presented at the 2021 ASH Annual Meeting. The abstract evaluates the efficacy and safety of fitusiran prophylaxis in a multicenter phase 3 study (ATLAS-INH) in patients with hemophilia A or B with inhibitors.
For coverage of the plenary scientific session, including this abstract and many other sessions, check www.ashpublications.org/ashnewsdaily throughout the meeting.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this podcast, Contributing Editor Dr. Damon Houghton has a conversation with Dr. Karlyn Martin. They discuss a Journal of Thrombosis and Haemostasis article covered by Dr. Houghton in his most recent Diffusion article titled, “Weighing the Risk and Benefits of Direct Oral Anticoagulants in Morbidly Obese Patients: New Data and Guidance.” In the article, Dr. Houghton discusses the updated recommendations from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee Subcommittee on Control of Anticoagulation on the use of direct oral anticoagulants in patients with obesity for the treatment and prevention of venous thromboembolism. You can access his Diffusion article online at: https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.6.2021610/477245/Weighing-the-Risk-and-Benefits-of-Direct-Oral.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment of our ASH Clinical Practice Guidelines and our COVID-19 series, Editor-in-Chief Dr. Laura Michaelis has a conversation with the Use of Anticoagulation in Patients with COVID-19 guideline panel co-chairs Dr. Adam Cuker and Dr. Reem Mustafa. They discuss the clinical importance of these guidelines as well as the process to track and respond to the ongoing emergence of new clinical data and evidence. For more information on these guidelines, and how you can get involved, visit www.hematology.org/VTEguidelines and for additional constantly-updated COVID-19 resources, visit www.hematology.org/covid-19.
While we regularly review and update the links, resources, and FAQs posted on the ASH website to reflect the best information available at a given point in time, the COVID-19 pandemic is a rapidly evolving global health crisis. Please take note of the dates of publication for each podcast.Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this podcast, Contributing Editor Dr. Adam Mead has a conversation with Dr. Elvin Wagenblast. They discuss Dr. Mead’s Diffusion article from the September/October 2021 issue of The Hematologist, titled, "Genome Editing: The Fetal Origins of Acute Myeloid Leukemia in Down Syndrome." They discuss a study that used CRISPR/Cas9 genome editing of hematopoietic stem and progenitor cells from human fetal liver to induce transient abnormal myelopoiesis– and myeloid leukemia associated with Down syndrome–related mutations. You can access his Diffusion article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.5.202159/476568/Genome-Editing-the-Fetal-Origins-of-Acute-Myeloid.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Neste podcast, Doutora Suely Rezende e Doutor Daniel Ribeiro, membros do Painel LATAM ASH TEV, conversam sobre a importância clínica das novas Diretrizes Para o Tratamento do Tromboembolismo Venoso na América Latina. Visite www.hematology.org/vte para mais informações e leia as diretrizes completas na publicação da Blood Advances: https://ashpublications.org/bloodadvances/article/5/15/3032/476514/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU?searchresult=1. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Spanish Version/Versión Español: En este pódcast, miembros del panel Panel LATAM ASH TEV, Dra. Cecilia Colorio y Dra. Cecilia Guillermo, conversan sobre la importancia clínica de las nuevas Guías Para el Manejo del Tromboembolismo Venoso para América Latina. Visite www.hematology.org/vte para mٔás información y lea las guías completas en una publicación de Blood Advances: https://ashpublications.org/bloodadvances/article/5/15/3032/476514/ASH-ABHH-ACHO-Grupo-CAHT-Grupo-CLAHT-SAH-SBHH-SHU?searchresult=1. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
English Version: In this podcast, 2021 ASH Guidelines for Management of Venous Thromboembolism in Latin American panel members Dr. Patricia Casais and Dr. Guillermo León Basantes have a conversation about the clinical importance of new Guidelines on Venous Thromboembolism in Latin America. Learn more by visiting www.hematology.org/vte, and read the full guideline in a Blood Advances publication via https://ashpublications.org/bloodadvances/article/5/15/3032/476514/. Additional membership and affiliation information for our speakers: Dr. Patricia Casais is a panel member of the ASH, ABHH, ACHO, Grupo CAHT, Grupo CLAHT, SAH, SBHH, SHU, SOMETH, Sociedad Panameña de Hematología, SPH, SVH, 2021 Guidelines for Management of Venous Thromboembolism in Latin America. Dr. Guillermo León Basantes is a member of the ACHO (Colombian Association of Oncology and Hematology) and Grupo CLATH. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Coming Soon: In an upcoming installment of our ASH Clinical Practice Guidelines series, panel members from the 2021 Guidelines for the Management of Venous Thromboembolism in Latin America will discuss the clinical importance of the new guidelines on VTE in Latin America. Join us each week for new episodes in English, Spanish, and Portuguese featuring panel members discussing the contextual factors for why these recommendations are so important to clinicians, patients, and other key stakeholders. Find additional information by visiting www.hematology.org/vte. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment of The Hematologist podcast, members of the ASH Taskforce on PhD Careers in Hematology Dr. Olga Guryanova and Dr. Andrew Volk have a conversation about the ASH Journal Club, a new series that will highlight seminal papers in hematology published in Blood and Blood Advances, featuring a manuscript author and moderated discussion. Learn more by visiting https://www.hematology.org/about/careers/resources-for-phds and Access the Journal Club via https://academy.hematology.org/local/catalog/view/product.php?productid=1170. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this podcast, Contributing Editor Dr. Saad Usmani has a conversation with Dr. Nikhil Munshi. They discuss Dr. Usmani’s Mini Review article from the July/August 2021 issue of The Hematologist, titled, "Immune Therapies for Myeloma: The CARs Are Here but What’s Next?" They discuss the latest approvals of chimeric antigen receptor T-cell therapies to treat multiple myeloma. You can access his Mini Review article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021413/476193/Immune-Therapies-for-Myeloma-The-CARs-Are-Here-but?utm_source=sfmc&utm_medium=email&utm_campaign=TheHem+July+2021&utm_term=Link+Text+%c2%bb&utm_id=102625&sfmc_id=32555314. Additional ASH affiliation and COI information: Dr. Usmani has received research funding from Amgen, Array Biopharma, BMS, Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX, and Takeda; consulting fees from Amgen, BMS, Celgene, EdoPharma, GSK, Janssen, Sanofi, Seattle Genetics, SecuraBio, SkylineDX, Takeda, and TeneoBio; speaker fees from Amgen, BMS, Janssen, and Sanofi. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this podcast, Contributing Editor Dr. Sarah Tasian has a conversation with Dr. Yoram Unguru. They discuss Dr. Tasian’s Feature article from the July/August 2021 issue of The Hematologist, titled, "Chemotherapy Drug Shortages in Pediatric Oncology: A Global Public Health Crisis Threatening Our Children." They shed light on chemotherapy drug shortages currently affecting pediatric cancer patients. You can access her Feature article online at https://ashpublications.org/thehematologist/article/doi/10.1182/hem.V18.4.2021412/476169/Chemotherapy-Drug-Shortages-in-Pediatric-Oncology. Additional ASH affiliation and COI information: Dr. Sarah Tasian serves on the Educational Program Advisory Panel for the 2021 ASH Annual Meeting and is a member of the Scientific Committee on Blood Disorders in Childhood. Dr. Tasian receives/d research funding from Incyte Corporation and Gilead Sciences and serves on the scientific advisory boards for Aleta Biotherapeutics and Kura Oncology. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment of our special COVID-19 podcast series, ASH Secretary Dr. Cindy Dunbar has a conversation with Dr. John Gribben. They discuss COVID-19 infection in patients with chronic lymphocytic leukemia or indolent lymphoma, including outcomes of infection, impact of CLL status and of treatment, changes to treatment approaches in the context of the pandemic, and the issues surrounding SARS-CoV-2 vaccine in these patients. Find additional ASH resources available to help the hematology community be prepared and proactive during the COVID-19 public health crisis, by visiting www.hematology.org/COVID-19. The article written by Drs. Martin Tallman and Jane Winter, mentioned by Dr. Dunbar in this podcast, is the July/August 2021 Presidents' Column for The Hematologist, and can be found online via https://ashpublications.org/thehematologist/article/476104/Masking-Vaccination-and-Research-Needed-to-Protect. If you have recommendations for topics to cover in this podcast series, please email us at thehematologist@hematology.org. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this installment of The Hematologist podcast, Chair of the ASH Hematology Review Series Task Force Dr. Leidy Isenalumhe and Chair of the ASH Trainee Council Dr. Lachelle Dawn Weeks have a conversation about the ASH Hematology Review Series, a free series designed for fellows preparing to take the internal medicine hematology certification examination or those desiring a comprehensive update. Learn more by visiting https://www.hematology.org/education/trainees/hematology-review-series. Access the review series via https://academy.hematology.org/local/catalog/view/product.php?productid=1171; you will be asked to create an account on the ASH Academy website. Additional affiliations: Dr. Isenalumhe is also a member of the ASH Committee on Education Subcommittee and was previously a member of the ASH Trainee Council from 2016-2018 and Chair from 2017-2018. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
In this podcast, Editor-in-Chief Dr. Laura Michaelis has a conversation with Contributing Editor Dr. Ifeyinwa (Ify) Osunkwo. They discuss Dr. Osunkwo’s Diffusion article from the May/June 2021 issue of The Hematologist, titled, "You Are What You Don’t Eat: Micro- and Macronutrient Deficiencies Linked to Worse Outcomes in Sickle Cell Disease." They talk about the influence of nutrition on disease severity and health-related quality of life in adults with sickle cell disease. You can access her Diffusion article online at https://ashpublications.org/thehematologist/article/475637/You-Are-What-You-Don-t-Eat-Micro-and-Macronutrient. Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/